Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real‐world evidence from the <scp>OPERA</scp> cohort

Gerald Pierone, Laurence Brunet, Jennifer S. Fusco, Michael G. Sension, Megan S. Dunbar, Joshua Gruber, Douglas T. Dieterich, Gregory P. Fusco

Open source

DOI: 10.1111/hiv.70105
Published: 2025-08-30
Container: HIV Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/hiv.70105,
  title = {Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real‐world evidence from the
                    <scp>OPERA</scp>
                    cohort},
  author = {Gerald Pierone and Laurence Brunet and Jennifer S. Fusco and Michael G. Sension and Megan S. Dunbar and Joshua Gruber and Douglas T. Dieterich and Gregory P. Fusco},
  year = {2025},
  journal = {HIV Medicine},
  doi = {10.1111/hiv.70105},
  url = {https://doi.org/10.1111/hiv.70105}
}

RIS

TY  - JOUR
TI  - Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real‐world evidence from the
                    <scp>OPERA</scp>
                    cohort
AU  - Gerald Pierone
AU  - Laurence Brunet
AU  - Jennifer S. Fusco
AU  - Michael G. Sension
AU  - Megan S. Dunbar
AU  - Joshua Gruber
AU  - Douglas T. Dieterich
AU  - Gregory P. Fusco
PY  - 2025
JO  - HIV Medicine
DO  - 10.1111/hiv.70105
UR  - https://doi.org/10.1111/hiv.70105
ER  -

APA

Pierone, G., Brunet, L., Fusco, J. S., Sension, M. G., Dunbar, M. S., Gruber, J., Dieterich, D. T., & Fusco, G. P. (2025). Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real‐world evidence from the <scp>OPERA</scp> cohort. HIV Medicine. https://doi.org/10.1111/hiv.70105

Source records

crossref · retrieved 2026-09-26T15:07:46.778Z